![William Conkling](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
William Conkling
Direktor/Vorstandsmitglied bei
IDT CORPORATION
Vermögen: 2 Mio $ am 30.06.2026
Profil
William Conkling is currently Director at Day Three Labs, Inc. and Cornerstone Pharmaceuticals, Inc. Mr. Conkling is also Independent Director at IDT Corp.
starting in 2026 and Chief Commercial Officer at Protara Therapeutics, Inc. starting in 2025.
Formerly, Mr. Conkling was President & Chief Executive Officer at Rafael Holdings, Inc. from 2023 to 2025, Independent Director at Cyclo Therapeutics, Inc. from 2023 to 2025, and Vice President-Sales, Marketing & Market Access at Immunomedics, Inc. from 2018 to 2021.
Education includes undergraduate studies at Fordham University and an MBA from The Leonard N Stern School of Business, conferred in 1998.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 18.11.2025 | 490.770 ( 0,96 % ) | 2 Mio $ | 30.06.2026 | |
| 02.06.2026 | 69.992 ( 0,12 % ) | 267 369 $ | 30.06.2026 | |
| 09.06.2026 | 673 ( 0 % ) | 39 142 $ | 30.06.2026 |
Aktive Positionen von William Conkling
| Unternehmen | Position | Beginn |
|---|---|---|
| PROTARA THERAPEUTICS, INC. | Corporate Officer/Principal | 02.06.2025 |
| IDT CORPORATION | Direktor/Vorstandsmitglied | 09.06.2026 |
Day Three Labs, Inc.
 Day Three Labs, Inc. Information Technology ServicesTechnology Services Provides proprietary technology services | Direktor/Vorstandsmitglied | - |
Cornerstone Pharmaceuticals, Inc.
 Cornerstone Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Develops anti-cancer drug delivery technology | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von William Conkling
| Unternehmen | Position | Ende |
|---|---|---|
| RAFAEL HOLDINGS, INC. | Vorstandsvorsitzender | 31.05.2025 |
| CYCLO THERAPEUTICS, INC. | Direktor/Vorstandsmitglied | 25.03.2025 |
| IMMUNOMEDICS, INC. | Vertrieb & Marketing | 01.03.2021 |
Ausbildung von William Conkling
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
66
Beziehungen ersten Grades
9
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 9 |
|---|---|
Immunomedics, Inc.
 Immunomedics, Inc. BiotechnologyHealth Technology Develops drugs for the treatment of cancer | Health Technology |
Cyclo Therapeutics, Inc.
 Cyclo Therapeutics, Inc. BiotechnologyHealth Technology Manufactures and sells cyclodextrins and related products | Health Technology |
IDT Corp.
 IDT Corp. Major TelecommunicationsCommunications Provides telecommunication and financial technology services | Communications |
Cornerstone Pharmaceuticals, Inc.
Cornerstone Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Develops anti-cancer drug delivery technology | Commercial Services |
Fordham University
 Fordham University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Leonard N Stern School of Business
 The Leonard N Stern School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Rafael Holdings, Inc.
 Rafael Holdings, Inc. Real Estate DevelopmentFinance Operates as holding company with interest in real estate and pharmaceutical sector | Finance |
Protara Therapeutics, Inc.
 Protara Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals | Health Technology |
Day Three Labs, Inc.
Day Three Labs, Inc. Information Technology ServicesTechnology Services Provides proprietary technology services | Technology Services |
